The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...

A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...

What exactly is optimal medical therapy (OMT) for angina relief? And how long should doctors prescribe it before proceeding to an invasive approach in symptomatic patients with stable ischemic heart ...

This large-scale open clinical trial of a new modified-release formulation of trimetazidine was conducted by 241 cardiologists in 906 patients with stable angina. All patients were required to have ...

Please provide your email address to receive an email when new articles are posted on . The study included data on 32,691 patients with stable CAD from the prospective, observational CLARIFY registry.

Angina is a type of chest pain produced by a decrease in blood flow to the heart. Angina is mostly an indication of coronary artery disease. Angina, commonly known as angina pectoris, produces ...

– The IMPROVE-ISCHEMIA Phase 2 clinical trial met the primary endpoint of tolerability and safety; 8-weeks treatment with ninerafaxstat also demonstrated a statistically significant improvement in ...

PHOENIX, AZ — Cardiologists commonly fail to recognize that an outpatient with stable CAD has had recent chest pain, so they do not escalate angina treatment, a study of more than 1000 outpatients ...

PARIS — Among a cohort of patients with stable CAD, angina yielded worse outcomes in patients with prior MI but did not make a difference in patients without prior MI, according to results from the ...